Special Issue

Topic: Role of Oncolytic Viruses in Cancer Therapy

A Special Issue of Journal of Translational Genetics and Genomics

ISSN 2578-5281 (Online)

Submission deadline: 31 May 2021

Guest Editor(s)

Prof. Robert Kratzke
Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.

Submission Deadline

31 May 2021

Submission Information

For Author Instructions, please refer to https://oaepublish.com/jtgg/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jtgg&SpecialIssueId=554
Submission Deadline: 31 May 2021
Contacts: Ryna Ni, Assistant Editor, Assistant_Editor@jtggjournal.com

Published Articles

Open Access Original Article

Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus

This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:423-42.
DOI: 10.20517/jtgg.2021.31
Available online: 4 Dec 2021
Open Access Review

Talimogene laherparepvec and novel injectable oncolytic viruses in the management of metastatic melanoma

This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:396-413.
DOI: 10.20517/jtgg.2021.29
Available online: 4 Nov 2021
Open Access Review

The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma

This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:304-22.
DOI: 10.20517/jtgg.2021.27
Available online: 3 Aug 2021
Journal of Translational Genetics and Genomics
ISSN 2578-5281 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/